Skip to main content
. 2017 Aug 15;2017(8):CD007476. doi: 10.1002/14651858.CD007476.pub3

7.13. Analysis.

7.13

Comparison 7 Transfusion‐dependent thalassemia: deferasirox + deferiprone vs deferiprone + deferoxamine, Outcome 13 Mild elevation of hepatic transaminases at start of therapy (# participants affected).